Table 1 Characteristics of patients and hospitals
Patient or hospital characteristic | Glucocorticoid group | Control group |
|---|---|---|
Number of participants, n | 600 | 211 |
Age (years), median [25th–75th percentiles] | 49 [38, 60] | 51 [35, 67] |
Sex, female, n (%) | 429 (71.5) | 127 (60.2) |
Charlson comorbidity index, median [25th–75th percentiles] | 1 [0, 1] | 1 [0, 2] |
Vasoactive-Inotropic Score, median [25th–75th percentiles] | 0 [0, 0] | 0 [0, 0] |
Consciousness, alert, n (%) | 338 (56.3) | 119 (56.4) |
Defibrillation, n (%) | 33 (5.5) | 6 (2.8) |
Mechanical ventilation use, n (%) | 208 (34.7) | 54 (25.6) |
Renal replacement therapy, n (%) | 58 (9.7) | 4 (1.9) |
Plasma exchange, n (%) | 24 (4.0) | 0 (0.0) |
Extra-corporeal membrane oxygenation n (%) | 27 (4.5) | 3 (1.4) |
Intra-aortic balloon pump, n (%) | 21 (3.5) | 4 (1.9) |
Acetaminophen use, n (%) | 213 (35.5) | 54 (25.6) |
Beta-blockers use, n (%) | 421 (70.1) | 112 (53.1) |
Methimazole use, n (%) | 512 (85.3) | 122 (57.8) |
Potassium Iodide use, n (%) | 432 (72.0) | 84 (39.8) |
Annual number of patients of thyroid storm per hospital, median [25th–75th percentiles] | 7 [4, 10] | 7 [3, 10] |
Admission number of ICU each day per hospital, median [25th–75th percentiles] | 5.4 [3.1, 7.4] | 5.1 [3.0, 8.3] |
Academic hospital, n (%) | 137 (22.8) | 50 (23.7) |